Supriya Lifesciences announced that the Board of Directors of the Company at its meeting held on 28 May 2024, inter alia, have recommended the final dividend of Rs 0.8 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Supriya Lifescience declined 3.40% to Rs 36.93 crore in the quarter ended March 2024 as against Rs 38.23 crore during the previous quarter ended March 2023. Sales rose 11.18% to Rs 158.18 crore in the quarter ended March 2024 as against Rs 142.27 crore during the previous quarter ended March 2023.For the full year,net profit rose 32.55% to Rs 119.11 crore in the year ended March 2024 as against Rs 89.86 crore during the previous year ended March 2023. Sales rose 23.74% to Rs 570.37 crore in the year ended March 2024 as against Rs 460.94 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales158.18142.27 11 570.37460.94 24 OPM %35.0838.69 -30.3327.96 - PBDT57.0856.30 1 181.50135.31 34 PBT53.1753.29 0 165.69123.49 34 NP36.9338.23 -3 119.1189.86 33 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 28 May 2024Powered by Capital Market - Live News

Net profit of Supriya Lifescience rose 212.92% to Rs 29.79 crore in the quarter ended December 2023 as against Rs 9.52 crore during the previous quarter ended December 2022. Sales rose 33.22% to Rs 140.07 crore in the quarter ended December 2023 as against Rs 105.14 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales140.07105.14 33 OPM %29.6213.35 - PBDT44.0715.59 183 PBT40.1112.64 217 NP29.799.52 213 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 7 February 2024. The meeting would commence at 11.00 am.Powered by Capital Market - Live News